A Study of HSP990 Administered by Mouth in Adult Patients With Advanced Solid Tumors
This study will study the safety, tolerability and metabolism of a drug called HSP990 when given by mouth once a week or twice weekly to subjects with advanced solid tumors.
Advanced Solid Malignancies
DRUG: HSP990
Maximum Tolerated Dose of HSP990 in patients treated once weekly or twice weekly, At the end of the dose escalation phase of the study
True DLT rate, At the end of the 1st 4 weeks of treatment|Preliminary Efficacy, Every 2 months (or 8 weeks, which equals 2 treatment cycles)|Drug metabolism in Humans, PK, PD, every 4 weeks
This study will study the safety, tolerability and metabolism of a drug called HSP990 when given by mouth once a week or twice weekly to subjects with advanced solid tumors.